These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 908031

  • 1. Inhibition of target cell mitosis as a measure of the cytostatic effects of activated macrophages on tumor target cells.
    Krahenbuhl JL, Remington JS.
    Cancer Res; 1977 Nov; 37(11):3912-6. PubMed ID: 908031
    [Abstract] [Full Text] [Related]

  • 2. Effects of activated macrophages on tumor target cells in discrete phases of the cell cycle.
    Krahenbuhl JL.
    Cancer Res; 1980 Dec; 40(12):4622-7. PubMed ID: 7438096
    [Abstract] [Full Text] [Related]

  • 3. Potential mechanism of macrophage-mediated tumor cell cytotoxicity.
    Kaplan AM, Collins JM, Morahan PS, Snodgrass MJ.
    Cancer Treat Rep; 1978 Nov; 62(11):1823-9. PubMed ID: 728900
    [Abstract] [Full Text] [Related]

  • 4. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM, Germain RN, Benacerraf B.
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [Abstract] [Full Text] [Related]

  • 5. Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.
    Ophir R, Ben-Efraim S, Bonta IL.
    Int J Tissue React; 1987 Mar; 9(3):189-94. PubMed ID: 3596960
    [Abstract] [Full Text] [Related]

  • 6. [Nonspecific in vitro cytotoxicity of activated human macrophages on human tumor cells (author's transl)].
    Nagai S.
    Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):2027-36. PubMed ID: 7211218
    [Abstract] [Full Text] [Related]

  • 7. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A, Lorinet AM, Thobie N, Halpern B.
    Ann Immunol (Paris); 1979 Dec; 130C(3):445-59. PubMed ID: 475346
    [Abstract] [Full Text] [Related]

  • 8. The role of activated macrophages in specific and nonspecific cytostasis of tumor cells.
    Krahenbuhl JL, Remington JS.
    J Immunol; 1974 Aug; 113(2):507-16. PubMed ID: 4210882
    [No Abstract] [Full Text] [Related]

  • 9. Studies of macrophage function during Trichinella spiralis infection in mice.
    Wing EJ, Krahenbuhl JL, Remington JS.
    Immunology; 1979 Mar; 36(3):479-85. PubMed ID: 437839
    [Abstract] [Full Text] [Related]

  • 10. A role for the macrophage in in vivo and in vitro resistance to murine bladder tumor cell growth.
    Droller MJ, Remington JS.
    Cancer Res; 1975 Jan; 35(1):49-53. PubMed ID: 1109796
    [Abstract] [Full Text] [Related]

  • 11. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ, Cornelius J.
    Cancer Res; 1987 Apr 15; 47(8):2067-72. PubMed ID: 3828996
    [Abstract] [Full Text] [Related]

  • 12. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE, Fidler IJ.
    Cancer Res; 1985 Jan 15; 45(1):14-8. PubMed ID: 3855280
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of macrophage-mediated tumor cell cytotoxicity.
    Kaplan AM, Brown J, Collins JM, Morahan PS, Snodgrass MJ.
    J Immunol; 1978 Nov 15; 121(5):1781-9. PubMed ID: 712065
    [No Abstract] [Full Text] [Related]

  • 14. Foreign-body tumorigenesis in mice: DNA synthesis in surface-attached cells during preneoplasia.
    Thomassen MJ, Buoen LC, Brand I, Brand KG.
    J Natl Cancer Inst; 1978 Aug 15; 61(2):359-63. PubMed ID: 277723
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous measurements of macrophage-induced cytostasis and cytotoxicity of EMT6 cells by flow cytometry.
    Stevenson AP, Martin JC, Stewart CC.
    Cancer Res; 1986 Jan 15; 46(1):99-105. PubMed ID: 3940215
    [Abstract] [Full Text] [Related]

  • 16. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H, Fujiwara H, Takai Y, Izumi Y, Sano S, Tsuchida T, Hamaoka T.
    J Immunol; 1985 Sep 15; 135(3):2199-205. PubMed ID: 3894520
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO, Johnson WJ, Marino PA.
    Fed Proc; 1982 Apr 15; 41(6):2212-21. PubMed ID: 6804274
    [Abstract] [Full Text] [Related]

  • 18. Predisposition of [125I]5-iodo-2'-deoxyuridine-labeled normal and neoplastic mouse fibroblasts to lysis by normal macrophages.
    Evans R, Eidlen DM.
    J Natl Cancer Inst; 1983 Nov 15; 71(5):983-9. PubMed ID: 6580500
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-mediated, antibody-dependent destruction of tumor cells in DBA/2 mice: in vitro identification of an in situ mechanism.
    Key M, Haskill S.
    J Natl Cancer Inst; 1981 Jan 15; 66(1):103-10. PubMed ID: 7005500
    [Abstract] [Full Text] [Related]

  • 20. Macrophage-induced enhancement of endogenous tumor lysosome activity.
    Urban JL.
    Cancer Res; 1981 Jun 15; 41(6):2221-9. PubMed ID: 7237422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.